US 10654842
Dopamine D3 receptor antagonist compounds
granted A61PA61P25/12A61P25/18
Quick answer
US patent 10654842 (Dopamine D3 receptor antagonist compounds) held by Indivior UK Limited expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/12, A61P25/18, A61P25/30, A61P43/00